The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis

Background Respiratory syncytial virus (RSV), a common respiratory pathogen, can lead to severe symptoms, especially in older adults (OA). A recently developed RSV prefusion F protein (RSVPreF3 OA) vaccine confers high protection against RSV lower respiratory tract disease (LRTD) over two full RSV s...

Full description

Bibliographic Details
Main Authors: Daisuke Kurai, Akiko Mizukami, Victor Preckler, Frederik Verelst, Daniel Molnar, Taizo Matsuki, Yufan Ho, Ataru Igarashi
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Expert Review of Vaccines
Subjects:
Japan
lower respiratory tract disease
older adults
public health impact
respiratory syncytial virus (RSV)
RSV prefusion F protein vaccine
Online Access:https://www.tandfonline.com/doi/10.1080/14760584.2024.2323128

Internet

https://www.tandfonline.com/doi/10.1080/14760584.2024.2323128

Similar Items